Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
455 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2017-06-20 (businesswire.com)
PAREXEL International Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
PAREXEL INTERNATIONAL ENTERS DEFINITIVE AGREEMENT TO BE ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT FOR $88.10 PER SHARE IN CASH
Read more
2013-10-30 (fiercebiotech.com)
Parexel's stock plunges despite spikes in revenue, profit
CRO giant Parexel International posted quarterly gains in sales and net income, but a dip in new business spooked investors, dropping the company's shares as much as 17% on Wednesday. | CRO giant Parexel International posted quarterly gains in sales and net income, but a dip in new business spooked
Read more
2013-02-01 (appliedclinicaltrialsonline.com)
Business and People: February 2013
Options have emerged that make DIY EDC technology more accessible to smaller organizations.
Read more
2012-05-02 (fiercebiotech.com)
Parexel experiences huge revenue and backlog growth in Q3
In its 3Q financial report, Parexel announced it earned $356 million in consolidated service revenue, an 18.1% increase from the same quarter last fiscal year. | In its 3Q financial report, Parexel announced it earned$ 356 million in consolidated service revenue, an 18.1% increase from the same
Read more